Home > Insider Trading > Filing (0001209191-21-009112)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1339970	Atyr Pharma Inc	LIFE	Biological Products, (No Disgnostic Substances) (2836)	203435077

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1671026	Sanjay Shukla	3545 John Hopkins Court, Suite #250 San Diego CA 92121	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-02-06	1,785	$0.00	9,076	No	4	M	Direct
Common Stock	Disposition	2021-02-09	778	$7.66	8,298	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2021-02-06	1,785	$0.00	1,785	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 6, 2019.
Restricted stock units convert into common stock on a one-for-one basis.
Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 6, 2019.
The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020.